Valuation: Libra Infusions Limited

Market Cap 153.36Cr 19TCr 139.68Cr 128.71Cr 117.08Cr 219.64Cr 14TCr 230.84Cr 1.57TCr 622.59Cr 7.76TCr 575.4Cr 563.27Cr 24TCr P/E 2016
131x
P/E 2017 107x
Enterprise Value 242.77Cr 30TCr 221.11Cr 203.74Cr 185.33Cr 347.69Cr 22TCr 365.42Cr 2.48TCr 985.57Cr 12TCr 910.87Cr 891.66Cr 39TCr EV / Sales 2016
6.88x
EV / Sales 2017 6.34x
Free-Float
99%
Yield 2016
0.41%
Yield 2017 0.57%
1 day-1.87%
1 week+2.22%
Current month-11.81%
1 month+5.28%
3 months-13.57%
6 months-3.96%
Current year-16.62%
1 week 510.5
Extreme 510.5
547.8
1 month 508.3
Extreme 508.3
623.8
Current year 501
Extreme 501
739
1 year 501
Extreme 501
739
3 years 501
Extreme 501
1,125
5 years 435
Extreme 435
1,146.67
10 years 238.33
Extreme 238.333332
1,146.67
Manager TitleAgeSince
Chief Executive Officer - 02/02/1976
Director of Finance/CFO - -
Comptroller/Controller/Auditor - -
Director TitleAgeSince
Director/Board Member - 21/06/2011
Chairman - 13/02/2013
Director/Board Member - 21/06/2011
Change 5-day change 1-year change 3-year change Capi.($)
-1.87%+2.22%-20.89%-30.17% 95.63L
-0.30%-6.68%+29.12%+125.42% 1,20000Cr
+1.25%-5.35%+33.19%+80.42% 65TCr
+0.94%-2.99%+24.73%+106.93% 51TCr
-0.60%-1.95%+27.26%+67.32% 38TCr
+0.69%-9.50%+40.80%+30.23% 33TCr
+0.41%-4.70%+27.23%+51.59% 29TCr
+0.81%-4.08%-1.74%+32.71% 27TCr
-0.15%-6.45%+29.63%+64.18% 24TCr
-0.06%-0.98%+33.15%+118.99% 21TCr
Average +0.14%-4.04%+22.25%+64.76% 41TCr
Weighted average by Cap. +0.40%-5.19%+28.03%+87.49%

Financials

2016 2017
Net sales 24Cr 2.97TCr 22Cr 20Cr 18Cr 34Cr 2.21TCr 36Cr 243.25Cr 97Cr 1.2TCr 89Cr 87Cr 3.78TCr 24Cr 3.04TCr 22Cr 20Cr 19Cr 35Cr 2.26TCr 37Cr 249.49Cr 99Cr 1.24TCr 92Cr 90Cr 3.88TCr
Net income 58.2L 73Cr 53.01L 48.85L 44.43L 83.36L 54Cr 87.61L 5.95Cr 2.36Cr 29Cr 2.18Cr 2.14Cr 92Cr 60.85L 76Cr 55.42L 51.07L 46.45L 87.15L 56Cr 91.59L 6.22Cr 2.47Cr 31Cr 2.28Cr 2.23Cr 97Cr
Net Debt 88Cr 11TCr 80Cr 74Cr 67Cr 125.97Cr 8.14TCr 132.39Cr 898.42Cr 357.08Cr 4.45TCr 330.01Cr 323.06Cr 14TCr 89Cr 11TCr 81Cr 75Cr 68Cr 128.05Cr 8.28TCr 134.58Cr 913.26Cr 362.98Cr 4.52TCr 335.47Cr 328.39Cr 14TCr
Logo Libra Infusions Limited
Libra Infusions Ltd is a Bangladesh-based company engaged in the manufacturing of Intravenous (I.V.) fluid. The Company's products include LIBOTT, LIBOTT-10, LIBOTT-25, LIBOTT-S, LIBOTT-S JR, NORMASOL, BABY SALINE, DIASOL, HARTSOL, LIBRAZOL, LIBRACIN, LIBOTT-M, LIBRACIN-400, and LIBRET. Its products are used in medical situations involving diarrheal disease, surgical operation, loss of blood, weakness and hospitalization in general. LIBOTT is used for rehydration in a time of water deficit, general weakness and post-surgical intervention. LIBOTT-10 is used for the treatment of jaundice, general weakness, eclampsia and pre-eclampsia. LIBOTT-25 is used in the emergency treatment of severe hypoglycemia. LIBOTT-S is used for rehydration during general weakness, water deficiency along with sodium, diuresis, intoxication and post-surgical intervention. LIBOTT-S JR fulfills the water deficit along with low deficiency of sodium chloride and supplies energy for growing children.
Employees
699
Date Price Change Volume
19/26/19 BDT 528.80 -1.87% 2,951
18/26/18 BDT 538.90 +0.48% 1,999
17/26/17 BDT 536.30 +2.78% 4,762
16/26/16 BDT 521.80 +1.05% 2,255
15/26/15 BDT 516.40 -0.17% 4,682
  1. Stock Market
  2. Stocks
  3. LIBRAINFU Stock